Shares in Cytori Therapeutics (NSDQ:CYTX) fell today after the biotech missed sales expectations on Wall Street with its second quarter results, but topped EPS estimates.
The San Diego, Calif.-based company posted a net loss of -$6 million on sales of $1.5 million for the 3 months ended June 30, for bottom-line growth of 6% on sales loss of -47% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Cytori Therapeutics posts mixed Q2 appeared first on MassDevice.
from MassDevice http://ift.tt/2uwYObG
Cap comentari:
Publica un comentari a l'entrada